SCHEMBL21282759

SCHEMBL21282759

CC(C)(C)OC(=O)Nc1cccc(NC(=O)c2cccc(NC(=O)/C=C/CN3CCOCC3)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.48
▸ BTK Q06187 1/20 0.48
▸ LMNA P02545 3/20 0.48
▸ CD274 Q9NZQ7 1/20 0.47
▸ PRMT5 O14744 1/20 0.47
▸ WDR77 Q9BQA1 1/20 0.47
▸ HDAC3 O15379 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ ERBB2 P04626 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ PARP14 Q460N5 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PLCG1 P19174 1/20 0.44
▸ CASR P41180 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28424597 1.00 EGFR (0.48) EGFRBTKLMNACD274PRMT5
SCHEMBL21282757 0.83 EGFR (0.51) EGFRBTKLMNAERBB2ALDH1A1
SCHEMBL28424241 0.83 EGFR (0.51) EGFRBTKLMNAERBB2ALDH1A1
SCHEMBL21282754 0.81 HDAC3 (0.53) LMNAPRMT5WDR77HDAC3HDAC1
SCHEMBL28421495 0.81 HDAC3 (0.53) LMNAPRMT5WDR77HDAC3HDAC1
SCHEMBL21282758 0.81 CDK14 (0.57) BTKHDAC3HDAC1HDAC2HDAC8
SCHEMBL28421375 0.81 CDK14 (0.57) BTKHDAC3HDAC1HDAC2HDAC8
SCHEMBL6814510 0.74 KDR (0.62) LMNACD274ALDH1A1SMN1; SMN2KMT2A
SCHEMBL31396764 0.73 KMT2A (0.59) LMNAPRMT5WDR77HDAC3HDAC1
SCHEMBL10130045 0.72 MAPK14 (0.60) EGFRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111247137-A Pyrimidine compound, preparation method and medical application thereof 恩瑞生物医药科技(上海)有限公司 2020-06-05 — — CN disclosed
WO-2019157959-A1 PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 恩瑞生物医药科技(上海)有限公司 2019-08-22 — — WO disclosed
Send feedback